The brilliant CFO genius of monoclonal antibody therapeutics headed for KBIO. AFFY now guaranteed BK, while KBIO set up for 1000%+ returns in the short-term. Easy money here.
AFFY worthless here, OMONTYS is worthless. Not only that, buy the only glimmer of hope AFFY had was brilliant officer CROSS, who jumped ship to create huge upside gains at KBIO. A winner likes to go with a winner.
this is AFFY mes board,you should be in KBIO bOARD...AND STOP NONESENSE....
I told you guys, start buying KBIO here!!
No hope left for AFFY investors here, it just makes sense to short before BK. The smart money is now taking long positions in KBIO, following CROSS is a good way to make huge upside returns.
Following that logic one would have made huge gains in AFFY. Why are you shilling for KBIO?